{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:25:07Z","timestamp":1793413507935,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1681\/asn.2009040421","type":"journal-article","created":{"date-parts":[[2010,1,14]],"date-time":"2010-01-14T20:33:46Z","timestamp":1263501226000},"page":"489-497","source":"Crossref","is-referenced-by-count":234,"title":["Rapamycin Ameliorates PKD Resulting from Conditional Inactivation of Pkd1"],"prefix":"10.1681","volume":"21","author":[{"given":"Jonathan M.","family":"Shillingford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus B.","family":"Piontek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G.","family":"Germino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Weimbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20230410","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1067\/mlc.2003.13","article-title":"Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology","volume":"141","author":"Sutters","year":"2003","journal-title":"J Lab Clin Med"},{"key":"R2-19-20230410","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.1523-1755.2005.00201.x","article-title":"Molecular pathogenesis of ADPKD: The polycystin complex gets complex","volume":"67","author":"Ong","year":"2005","journal-title":"Kidney Int"},{"key":"R3-19-20230410","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R4-19-20230410","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/jnci\/djm288","article-title":"Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1\/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys","volume":"100","author":"Baba","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R5-19-20230410","doi-asserted-by":"crossref","first-page":"e3581","DOI":"10.1371\/journal.pone.0003581","article-title":"Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia","volume":"3","author":"Chen","year":"2008","journal-title":"PLoS ONE"},{"key":"R6-19-20230410","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R7-19-20230410","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R8-19-20230410","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000104818","article-title":"Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease","volume":"30","author":"Wu","year":"2007","journal-title":"Kidney Blood Press Res"},{"key":"R9-19-20230410","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1093\/ndt\/gfp129","article-title":"Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD)","volume":"24","author":"Zafar","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R10-19-20230410","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1681\/ASN.2007020155","article-title":"Autosomal dominant polycystic kidney disease: Time for a change?","volume":"18","author":"Chapman","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R11-19-20230410","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.2215\/CJN.05611207","article-title":"Mammalian target of rapamycin and caspase inhibitors in polycystic kidney disease","volume":"3","author":"Edelstein","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-19-20230410","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/ndt\/gfl246","article-title":"Therapeutic approaches in autosomal dominant polycystic kidney disease (ADPKD): Is there light at the end of the tunnel?","volume":"21","author":"Walz","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R13-19-20230410","doi-asserted-by":"crossref","first-page":"F1423","DOI":"10.1152\/ajprenal.00275.2007","article-title":"Polycystic kidney disease and renal injury repair: Common pathways, fluid flow, and the function of polycystin-1","volume":"293","author":"Weimbs","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"R14-19-20230410","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study","volume":"8","author":"Serra","year":"2007","journal-title":"BMC Nephrol"},{"key":"R15-19-20230410","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"R16-19-20230410","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","article-title":"A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo","volume":"15","author":"Piontek","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R17-19-20230410","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0960-9822(02)70717-3","article-title":"Bypass of lethality with mosaic mice generated by Cre-loxP-mediated recombination","volume":"6","author":"Betz","year":"1996","journal-title":"Curr Biol"},{"key":"R18-19-20230410","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1523-1755.2000.00205.x","article-title":"Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation","volume":"58","author":"Okada","year":"2000","journal-title":"Kidney Int"},{"key":"R19-19-20230410","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/ndt\/gfl071","article-title":"Gene profiling of polycystic kidneys","volume":"21","author":"Schieren","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R20-19-20230410","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2005101032","article-title":"Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes","volume":"17","author":"Chen","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R22-19-20230410","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1126\/science.1106148","article-title":"Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex","volume":"307","author":"Sarbassov","year":"2005","journal-title":"Science"},{"key":"R23-19-20230410","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-05-2925","article-title":"mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt","volume":"66","author":"O'Reilly","year":"2006","journal-title":"Cancer Res"},{"key":"R24-19-20230410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","article-title":"Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB","volume":"22","author":"Sarbassov","year":"2006","journal-title":"Mol Cell"},{"key":"R25-19-20230410","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1203\/01.PDR.0000147727.78571.07","article-title":"Effects of rapamycin in the Eker rat model of tuberous sclerosis complex","volume":"57","author":"Kenerson","year":"2005","journal-title":"Pediatr Res"},{"key":"R26-19-20230410","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1681\/ASN.2007101139","article-title":"Pkd1 inactivation induced in adulthood produces focal cystic disease","volume":"19","author":"Takakura","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R27-19-20230410","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1681\/ASN.2007050626","article-title":"Sirolimus reduces polycystic liver volume in ADPKD patients","volume":"19","author":"Qian","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R28-19-20230410","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.21331","article-title":"Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex","volume":"63","author":"Zeng","year":"2008","journal-title":"Ann Neurol"},{"key":"R29-19-20230410","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1523-1755.2005.00731.x","article-title":"Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: A novel approach for tailored immunosuppressive therapy","volume":"68","author":"Hartmann","year":"2005","journal-title":"Kidney Int"},{"key":"R30-19-20230410","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199203000-00002","article-title":"The effect of rapamycin on kidney function in the Sprague-Dawley rat","volume":"53","author":"DiJoseph","year":"1992","journal-title":"Transplantation"},{"key":"R31-19-20230410","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"R32-19-20230410","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","article-title":"Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD)","volume":"24","author":"Fischer","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R33-19-20230410","first-page":"133","article-title":"Rapamycin reduces kidney volume and delays the loss of renal function in a patient with autosomal-dominant polycystic kidney disease","volume":"2","author":"Peces","year":"2009","journal-title":"Nephrol Dial Transplant Plus"},{"key":"R34-19-20230410","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1046-2023(03)00025-2","article-title":"SNAREs and epithelial cells","volume":"30","author":"Weimbs","year":"2003","journal-title":"Methods"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201003000-00019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:32:11Z","timestamp":1786131131000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201003000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2009040421","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}